The city of Boston recently announced it reached an agreement with the group that covers unionized employees and retirees to pull back on nonspecialty drugs, including GLP-1s
If you've been shedding pounds lately, you may notice a lower tolerance for cold and a need for an extra layer or two
Patients should always work with their healthcare provider to monitor for side effects and adjust treatment as needed
The most recent Phase 3 trial showed discontinuation rates of 12-18% due to adverse events, higher than existing GLP-1 medications
Without pharmaceutical-grade manufacturing standards, independent batch testing, and validated stability data, there is no reliable way for an individual to confirm the potency, purity, or safety of any such product
Strong clinical evidence demonstrating sustained weight loss and cardiometabolic benefits is boosting confidence among patients and healthcare providers